Abstract
Cytokines are low molecular weight proteins that are produced transiently by almost any eukaryotic cell. They exert their biological activities via interaction with specific cell surface receptors, which are expressed in relatively low numbers. There is evidence for a network of interacting cytokines, as they usually have multiple overlapping activities [10]. Cytokines may induce each other or interfere with the expression of their receptors and thus can affect cell function in a synergistic, additive or antagonistic way. The cytokine family consists of interleukins, chemokines, tumor necrosis factors, colony-stimulating factors, interferons, growth factors and suppressor factors. In this review mainly cytokines of special significance for the regulation of cutaneous immune and inflammatory responses will be discussed, whereas most other cytokines and mediators will only be mentioned briefly.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC, Miyajima A, Puri RK, Paul WE et al. (1993) Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor [see comments]. Science 262: 1880–1883
Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ (1993) Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor [see comments]. Science 262: 1877–1880
Ishii N, Asao H, Kimura Y, Takeshita T, Nakamura M, Tsuchiya S, Konno T, Maeda M, Uchiyama T, Sugamura K (1994) Impairment of ligand binding and growth signaling of mutant IL-2 receptor gammachains in patients with X-linked severe combined immunodeficiency. J Immunol 153: 1310–1317
Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG (1994) Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264: 965–969
Adolf GR, Grell M, Scheurich P (1993) Tumor necrosis factor. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 63–88
Aebischer I, Stämpfli MR, Zürcher A, Miescher S, Urwyler A, Frey B, Luger TA, White RR, Stadler BM (1994) Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesis. Eur J Immunol 24: 1908–1913
Akira S, Taga T, Kishimoto T (1993) Interleukin-6 in biology and medicine. Adv Immunol 54: 1–78
Ambrus JLJ, Pippin J, Joseph A, Xu C, Blumenthal D, Tamayo A, Claypool K, McCourt D, Srikiatchatochorn A, Ford RJ (1993) Identification of a cDNA for a human high-molecular-weight B-cell growth factor. Proc Natl Acad Sci USA 90: 6330–6334
Appasamy PM (1993) Interleukin-7: biology and potential clinical applications. Cancer Invest 11: 487–499
Aragane Y, Bhardway RS, Simon MM, Schwarz A, Rieman H, Luger TA, Schwarz T (1994) Detection of keratinocyte-derived interleukin-4. J Invest Dermatol 102: 586
Aragane Y, Riemann H, Bhardwaj RS, Schwarz A, Sawada Y, Yamada H, Luger TA, Kubin M, Trinchieri G, Schwarz T (1995) Interleukin 12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 154 (in press)
Aversa G, Punnonen J, Cocks BG, de Waal Malefyt R, Vega FJ, Zurawski SM, Zurawski G, de Vries JE (1993) An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 178: 2213–2218
Baggiolini M, Dahinden CA (1994) Chemokines in allergic inflammation. Immunol Today 15: 127–133
Balkwill FR, Burke F (1989) The cytokine network. Immunol Today 10: 299–304
Barker JN, Jones ML, Swenson CL, Sarma V, Mitra RS, Ward PA, Johnson KJ, Fantone JC, Dixit VM, Nickoloff BJ (1991) Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-gamma. J Immunol 146: 1192–1197
Becker D, Knop J (1993) Epidermal cell-derived cytokines and delayed-type hypersensitivity. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 365–376
Bhardwaj RS, Aragane Y, Becher E, Schwarz A, Riemann H, Schwarz T, Luger TA (1994) Alpha-melanocyte stimulating hormone differentially regulates interleukin 10 production by human peripheral mononucler cells. J Invest Dermatol 102: 586
Bieber T (1992) IgE-Rezeptoren auf Langehans-Zellen. Hautarzt 43: 753–762
Bieber T (1994) FceRI on human Langerhans cells: a receptor in search of new functions. Immunol Today 15: 52–53
Birchall N, Park L, Kupper T (1988) IL-4 binds to specific cell surface receptors on human keratinocytes and induces colony stimulating factor release and HLA-DR expression. Clin Res 36: 374A
Briere F, Servet-Delprat C, Bridon JM, Saint-Remy JM, Banchereau J (1994) Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med 179: 757–762
Brown SL, Blalock JE (1990) Neuroendocrine Immune Interactions. In: Oppenheim JJ, Shevach EM (eds) Immunophysiology, the role of cells and cytokines in immunity and inflammation. Oxford University Press, Oxford, pp 306–319
Brunda MJ (1994) Interleukin-12. J Leukoc Biol 55: 280–288
Cannon JG, Tatro JB, Reichlin S, Dinarello CA (1986) Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 137: 2232–2236
Coffman RL, O’Garra A, Volkmann D (1990) Interleukins and interferons acting on B-lymphocytes. In: Oppenheim JJ, Shevach EM (eds) Immunophysiology; the role of cells and cytokines in immunity and inflammation. Oxford University Press, New York, pp 88–103
Cork MJ, Duff GW (1993) Interleukin one. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 19–48
Dinarello CA (1989) Interleukin-1 and its biologically related cytokines. Adv Immunol 44: 153–205
Dinarello CA, Thompson RC (1991) Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 12: 404–410
Dreno B, Hallet MM, Moisan JP, Soulillou JP, Jacques Y (1989) Interleukin 2-like material in human epidermis: a ligand for the human interleukin 2-receptor 55 kD alpha chain. J Invest Dermatol 93: 78–82
Druez C, Coulie P, Uyttenhove C, Van Snick J (1990) Functional and biochemical characterization of mouse P40/IL-9 receptors. J Immunol 145: 2494–2499
Dugas B, Renauld JC, Pene J, Bonnefoy JY, Peti Frere C, Braquet P, Bousquet J, Van Snick J, Mencia Huerta JM (1993) Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 23: 1687–1692
Durum SK, Oppenheim JJ, Neta R (1990) Immunophysiologic role of interleukin-1 In: Oppenheim JJ, Shevach EM (eds) Immunophysiology; the role of cells and cytokines in immunity and inflammation. Oxford University Press, New York, pp 210–225
Enk A, Katz SI (1992) Identification and Induction of keratinocyte-derived IL-10. J Immunol 149: 92–95
Enk AH, Angeloni VL, Udey MC, Katz SI (1993) An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in the skin. J Immunol 150: 3698–3704
Enk AH, Katz SI (1992) Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A 89: 1398–1402
Enk AH, Saloga J, Becker D, Mohamadzadeh M, Knop J (1994) Induction of hapten-specific tolerance by interleukin 10 in ivio. J Exp Med 179: 1397–1402
Farrar MA, Schreiber RD (1993) The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11: 571–611
Friedman RM (1990) Interferons. In: Oppenheim JJ, Shevach EM (eds) Immunophysiology. The role of cells and cytokines in immunity and inflammation. Oxford University Press, New York, pp 194–209
Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177: 547–550
Gillitzer R, Wolff K, Tong D, Muller C, Yoshimura T, Hartmann AA, Stingl G, Berger R (1993) MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101: 127–131
Grabbe S, Bruvers S, Granstein RD (1994) Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen presenting cells. J Invest Dermatol 102: 67–73
Grabbe S, Granstein RD (1994) Mechanisms of ultraviolet radiation carcinogenesis. In: Granstein RD (ed) Mechanisms of immune regulation. Karger, Basel, pp 291–313
Gubler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nabavi N, Wolitzky AG, Quinn PM, Familletti PC, Gately MK (1991) Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A 88: 4143–4147
Hanifm JM, Schneider LC, Leung DY, Ellis CN, Jaffe HS, Izu AE, Bucalo LR, Hirabayashi SE, Tofte SJ, Cantu Gonzales G, Milgrom H, Boguniewicz M, Cooper KD (1993) Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 28: 189–197
Henney CS (1989) Interleukin 7: effects on early events in lymphopoiesis. Immunol Today 10: 170–173
Heufler C, Topar G, Grasseger A, Stanzl U, Koch F, Romani N, Namen AE, Schuler G (1993) Interleukin 7 is produced by murine and human keratinocytes. J Exp Med 178: 1109–1114
Hirano T, Akira S, Taga T, Kishimoto T (1990) Biological and clinical aspects of interleukin 6. Immunol Today 12: 443–449
Ho ASY, Liu Y, Khan TA, Hsu DH, Bazan JF, Moore KW (1993) A receptor for interleukin-10 is related interferon receptors. Proc Natl Acad Sci U S A 90: 11267–11271
Holter W (1992) Regulation of interleukin 4 production and of interleukin 4-producing cells. Int Arch Allergy Immunol 98: 273–278
Jessup JM, Hanna N, Palaszynski E, Kripke ML (1978) Mechanisms of depressed reactivity to dinitrochlorobenzene and ultraviolet-induced tumors during ultraviolet carcinogenesis in BALB/c mice. Cell Immunol 38: 105–115
Jinquan T, Larsen CG, Gesser B, Matsushima K, Thestrup Pedersen K (1993) Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J Immunol 151: 4545–4551
Kaplan G, Walsh G, Guido LS, Meyn P, Burkhardt RA, Abalos RM, Barker J, Frindt PA, Fajardo TT, Celona R, Cohn ZA (1992) Novel responses of human skin to intradermal granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med 175: 1717–1728
Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW (1992) Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 148: 3618–3623
Kirnbauer R, Köck A, Schwarz T, Urbanski A, Krutmann J, Borth W, Damm D, Shipley G, Ansel JC, Luger TA (1989) IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 142: 1922–1928
Koch F, Heufler C, Kampgen E, Schneeweiss D, Bock G, Schuler G (1990) Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J Exp Med 171: 159–171
Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Köhler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339–342
Köck A, Schauer E, Schwarz T, Luger TA (1991) Human keratinocytes synthesize and release neuropeptides such as a-MSH and ACTH. In: Meltzer M, Mantovani A (eds) Cellular and cytokine networks in tissue immunity. Wiley, New York, pp 105–110
Leonard EJ, Yoshimura T (1990) Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11: 97–101
Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating fator. N Engl J Med 327: 28–35
Liu Y, Wei SHY, Ho ASY, de Waal Malefyt R, Moore KW (1994) Expression cloning ‘and characterization of a human IL-10 receptor. J Immunol 152: 1821–1829
Longley J, Rochester C, Tyrrell L, Einarson O, Elias J (1993) Interleukin 11 (IL-11) in normal skin and sarkoidosis. J Invest Dermatol 100: 524
Luger TA, Krutmann J, Kirnbauer R, Urbanski A, Schwarz T, Klappacher G, Köck A, Micksche M, Malejczyk J, Schauer E, May LT, Sehgal PB (1989) IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol 143: 1206–1209
Luger TA, Schauer E, Trautinger F, Krutmann J, Ansel J, Schwarz A, Schwarz T (1993) Production of immunosuppressing melanotropins by keratinocytes. Ann N Y Acad Sci 680: 567–570
Luger TA, Trautinger F, Schwarz T (1993) Cytokines: therapeutic aspects for skin diseases. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 453–474
Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinchieri G (1994) Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J Exp Med 179: 1273–1284
Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177: 1199–1204
Massague J (1987) The TGF-beta family of growth and differentiation factors. Cell 49: 437–438
Matsue H, Cruz PD Jr, Bergstresser PR, Takashima A (1992) Langerhans cells are the major source of mRNA for IL-1 beta and MIP-1 alpha among unstimulated mouse epidermal cells. J Invest Dermatol 99: 537–541
Matsushima K, Oppenheim JJ (1989) Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1: 2–13
McKenzie RC, Lea RG, Sauder DN (1991) Ultraviolet radition induces expression of interleukin 8 and transforming growth factor beta in human keratinocytes. J Invest Dermatol 96: 610
Mihara M, Ikuta M, Koishihara Y, Ohsugi Y (1991) Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis. Eur J Immunol 21: 2327–2331
Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D (1993) Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248–250
Montaner LJ, Doyle AG, Collin M, Herbein G, Illei P, James W, Minty A, Caput D, Ferrara P, Gordon S (1993) Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J Exp Med 178: 743–747
Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11: 165–190
Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248: 1230–1234
Mosmann TR, Moore KW (1991) The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 12: A49–A53
Mullarkey MF, Leiferman KM, Peters MS, Caro I, Roux ER, Hanna RK, Rubin AS, Jacobs CA (1994) Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor. J Immunol 152: 2033–2041
Neben S, Turner K (1993) The biology of interleukin 11. Stem Cells Dayt 11 [Suppl 2]: 156–162
Niederkorn JY (1990) Immune priviledge and immune regulation in the eye. Adv Immunol 48: 191–226
Nishimoto N, Ogata A, Shima Y, Tani Y, Ogawa H, Nakagawa M, Sugiyama H, Yoshizaki K, Kishimoto T (1994) Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, GP130. J Exp Med 179: 1343–1348
Palmetshofer A, Schwarz A, Mahnke K, Bhardwaj RS, Luger TA, Schwarz T (1994) Interleukin-10 affects the expression of adhesion molecules on human dermal microvascular endothelial cells. Exp Derm 3: 138
Paul SR, Schendel P (1992) The cloning and biological characterization of recombinant human interleukin 11. Int J Cell Cloning 10: 134–142
Paul WE (1991) Interleukin 4: a prototypic immunoregulatory lymphokine. Blood 77: 1859–1870
Piguet PF, Grau GE, Hauser C, Vassalli P (1991) Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 173: 673–679
Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE (1993) Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 90: 3730–3734
Renauld JC, Houssiau F, Louahed J, Vink A, Van Snick J, Uyttenhove C (1993) Interleukin-9. Adv Immunol 54: 79–97
Rheins LA, Cotleur AL, Kleier RS, Hoppenjans WB, Sauder DN, Nordlund JJ (1989) Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J Invest Dermatol 93: 511–517
Rivas JM, Ullrich SE (1992) Keratinocyte-derived IL-10. J Invest Dermatol 98: 578
Rivas JM, Ullrich SE (1992) Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 149: 3865–3871
Roberts AB, Sporn MB (1990) The transforming growth factor-betas. In: Sporn MB, Roberts AB (eds) Handbook of experimental pharmacology. I. Peptide growth factors and their receptors. Springer, Berlin Heidelberg New York, pp 419–472
Robertson B, Dostal K, Daynes RA (1988) Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocytestimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J Immunol 140: 4300–4307
Rode HJ, Janssen W, Rosen Wolff A, Bugert JJ, Thein P, Becker Y, Darai G (1993) The genome of equine herpesvirus type 2 harbors an interleukin 10 (IL10)-like gene. Virus Genes 7: 111–116
Romani N, Heufler C, Koch F, Topar G, Kämpgen E, Schuler G (1993) Cytokines and Langerhans cells. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 345–364
Ruscetti FW (1990) Interleukin-2 In: Oppenheim JJ, Shevach EM (eds) Immunophysiology; the role of cells and cytokines in immunity and inflammation. Oxford University Press, New York, pp 46–66
Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109–1118
Scarborough DE (1990) Cytokine modulation of pituitary hormone secretion. In: O’Dorisio MS, Panerai A (eds) Neuropeptides and immunopeptides: messengers in a neuroimmune axis. Annals of the New York Academy of Science, New York, pp 169–187
Schauer E, Trautinger F, Köck A, Bhardwaj RS, Simon M, Schwarz A, Ansel JC, Schwarz T, Luger TA (1994) Proopiomelanocortin derived peptides are synthesized and released by human keratinocytes. J Clin Invest 93: 2258–2262
Schrader JW (1993) Colony stimulating factors and the skin. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 147–162
Schreiber S, Kilgus O, Payer E, Kutil R, Elbe A, Mueller Ch, Sting’ G (1992) Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 149: 3525–3534
Schröder JM, Sticherling M, Smid P, Christophers E (1993) Interleukin 8 and structurally related cytokines. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 89–112
Schwarz A, Grabbe S, Riemann H, Aragane Y, Simon M, Manon S, Andrade S, Luger TA (1994) In vivo effects of IL-10 on contact hypersensitivity and delayed type hypersensitivity reactions. J Invest Dermatol 103: 211–216
Schwarz A, Krone C, Trautinger F, Aragane Y, Neuner P, Luger TA, Schwarz T (1993) Pentoxifylline suppresses irritant and contact hypersensitivity reactions. J Invest Dermatol 101: 549–552
Schwarz T, Luger TA (1992) Pharmacology of cytokines in the skin. In: Muhktar H (ed) Pharmacology of the skin. CRC Press, Boca Raton, pp 283–314
Schwarz T, Schwarz A, Krone C, Luger TA (1993) Pentoxifylline suppresses allergic patch test reactions in humans. Arch Dermatol 129: 513–514
Schwarz T, Urbanski A, Gschnait F, Luger TA (1986) Inhibition of the induction of contact hypersensitivity by a UV-mediated epidermal cytokine. J Invest Dermatol 87: 289–291
Sehgal PB (1990) Interleukin-6: molecular pathophysiology. J Invest Dermatol 94: 2S–6S
Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily’ of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959–962
Streilein JW (1993) Immunobiology of the skin. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 1–16
Streilein JW, Taylor JR, Vincek V, Kurimoto I, Shimizu T, Tie C, Golomb C (1994) Immune surveillance and sunlight induced skin cancer. Immunol Today 15: 174–179
Taga T, Murakami M, Narazaki M, Hibi M, Saito M, Yoshida K, Yawata H, Yasukawa K, Kishimoto T (1992) The mechanism of IL-6 signaling through the IL-6 receptor associated signal transducer, gp130. In: Revel M (ed) IL-6: physiopathology and clinical potentials. Raven, New York, pp 43–53 (Serono Symposia, vol 88)
Taniguchi T (1992) Structure and function of IL-2 and IL-2 receptors. Behring Inst Mitt 91: 87–95
Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G (1991) A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66: 1175–1184
Trefzer U, Brockhaus M, Lötscher H, Parlow F, Budnik A, Grewe M, Christoph I-I, Schöpf E, Luger TA, Krutmann J (1993) The 55-kd tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor alpha and by ultraviolet B radiation. J Clin Invest 92: 462–470
Trinchieri G (1993) Interleukin-12 and its role in the generation of Thl cells. Immunol Today 14: 335–338
Vora M, Karasek MA (1994) IL-10 induces and upregulates the expression of E-selectin by inflammatory cytokines or LPS on human dermal microvascular endothelial cells. J Invest Dermatol 102: 636
Wahl SM (1993) Regulation of tissue inflammation, repair, and fibrosis by transforming growth factor beta. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 241–252
Wahl SM, McCartney Francis N, Mergenhagen SE (1989) Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today 10: 258–261
Waldmann TA (1993) The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunol Today 14: 264–270
Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kelleher K, Herrmann SH, Clark SC, Azzoni L, Chan SH, Trinchieri G, Perusia B (1991) Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146: 3074–3081
Yoshizaki K, Kishimoto T (1993) Interleukin 6. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Dekker, New York, pp 4962
Zhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B (1994) Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 transducer GP130. J Exp Med 179: 1337–1342
Zurawski G, de Vries JE (1994) Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15: 19–26
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Luger, T.A., Schwarz, T. (1995). Cytokines and Neuroendocrine Hormones as Mediators of Cutaneous Immunity and Inflammation. In: Eibl, M.M., Huber, C., Peter, H.H., Wahn, U. (eds) Symposium in Immunology IV. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79446-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-79446-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58769-9
Online ISBN: 978-3-642-79446-9
eBook Packages: Springer Book Archive